Testing effectiveness (Phase 2)Ended earlyNCT02013375What this trial is testingSCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCDWho this might be right forSickle Cell Disease Damiano Rondelli, MD 2
Testing effectiveness (Phase 2)Looking for participantsNCT05260957What this trial is testingCAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).Who this might be right forRefractory Non-Hodgkin LymphomaRelapsed Non Hodgkin LymphomaAggressive Non-Hodgkin Lymphoma Lazaros Lekakis 22
Large-scale testing (Phase 3)Study completedNCT00866203What this trial is testingHDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction TherapyWho this might be right forHigh-Grade Lymphomas Gruppo Italiano Studio Linfomi 441
Testing effectiveness (Phase 2)Looking for participantsNCT06238648What this trial is testingEpcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T TherapyWho this might be right forDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-Cell LymphomaTransformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Academic and Community Cancer Research United 120
Large-scale testing (Phase 3)Study completedNCT00114543What this trial is testingTrial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth WeightWho this might be right forHyperbilirubinemia, NeonatalJaundice, NeonatalInfant, Newborn+3 more NICHD Neonatal Research Network 1,974
Not applicableUnknownNCT03270813What this trial is testingRAGE-Control: Teaching Emotional Self-regulation Through Videogame PlayWho this might be right forAngerAggression Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01735630What this trial is testingEfficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease OPKO Health, Inc. 350
Early research (Phase 1)Ended earlyNCT00671112What this trial is testingEverolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaWho this might be right for714leukemiaLymphoma Brian Hill, MD, PhD 30
Testing effectiveness (Phase 2)UnknownNCT02678299What this trial is testingPhase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN StudyWho this might be right forMalignant Lymphoma University of Aarhus 60
Testing effectiveness (Phase 2)Looking for participantsNCT03938987What this trial is testingAnti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)Who this might be right forRelapsed Non Hodgkin LymphomaRelapsed Adult ALLRelapsed Pediatric ALL University of Alberta 63
Not applicableUnknownNCT03048045What this trial is testingLong-term Results After Systematic Periodontal TherapyWho this might be right forTooth Loss Goethe University 100
Early research (Phase 1)Active Not RecruitingNCT04231877What this trial is testingPolatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell LymphomaWho this might be right forAggressive Non-Hodgkin LymphomaALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more University of Washington 56
Not applicableStudy completedNCT00621751What this trial is testingCarbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and AggressionWho this might be right forTraumatic Brain Injury Wake Forest University Health Sciences 70
Large-scale testing (Phase 3)Looking for participantsNCT05257629What this trial is testingAggressive Smoking Cessation Trial (ASAP)Who this might be right forAcute Coronary SyndromeCardiovascular Diseases Sir Mortimer B. Davis - Jewish General Hospital 798
Testing effectiveness (Phase 2)Active Not RecruitingNCT04531046What this trial is testingAxi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell TransplantationWho this might be right forB-Cell Lymphoma RefractoryB-cell Lymphoma Recurrent The Lymphoma Academic Research Organisation 62
Testing effectiveness (Phase 2)UnknownNCT03837873What this trial is testingDLCL002 Protocol for Patients With High Risk Aggressive B-cell LymphomaWho this might be right forDiffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma Institute of Hematology & Blood Diseases Hospital, China 118
Not applicableStudy completedNCT07526883What this trial is testingThe Effect of Non-Surgical Periodontal Treatment on Systemic Inflammatory Markers and Lipid Profile in Young Adults With Severe PeriodontitisWho this might be right forPeriodontitis, Aggressive Istanbul University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03625037What this trial is testingFirst-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell LymphomaWho this might be right forDLBCLHigh-grade B-cell Lymphoma (HGBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)+6 more Genmab 666
Post-approval studies (Phase 4)Study completedNCT02048241What this trial is testingIntuniv vs Placebo in the Treatment of Childhood Intermittent Explosive DisorderWho this might be right forIntermittent Explosive DisorderChildhood AggressionOppositional Defiant Disorder+1 more New York State Psychiatric Institute 11
Post-approval studies (Phase 4)Study completedNCT02852694What this trial is testingReduce Risk for Crohn's Disease PatientsWho this might be right forCrohn's Disease PIBD-Net 192